Invention Grant
- Patent Title: Carbazole compounds useful as bromodomain inhibitors
-
Application No.: US15430883Application Date: 2017-02-13
-
Publication No.: US10196387B2Publication Date: 2019-02-05
- Inventor: Michael A. Poss , David R. Tortolani , Ashok Vinayak Purandare , John S. Tokarski , Christopher P. Mussari , Muthoni G. Kamau , Dharmpal S. Dodd , Ashvinikumar V. Gavai , Daniel O'Malley , Tram N. Huynh , Wayne Vaccaro , Lalgudi S. Harikrishnan
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- Main IPC: C07D413/04
- IPC: C07D413/04 ; C07D413/14 ; C07D417/14 ; C07D413/10 ; A61K31/422 ; A61K31/427 ; A61K31/4439 ; A61K31/454 ; A61K31/5355 ; A61K31/5377 ; A61K31/541 ; A61K31/553
Abstract:
The present invention is directed to carbazole compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Public/Granted literature
- US20170152248A1 CARBAZOLE COMPOUNDS USEFUL AS BROMODOMAIN INHIBITORS Public/Granted day:2017-06-01
Information query
